{"entity":{"type":"insider","cik":"0001291969","url":"/insider/0001291969","json_url":"/insider/0001291969.json","name":"Aasen Thomas H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":14,"first":"2006-02-17","last":"2014-04-04","span_basis":"filed_date"},"name_variants":[{"name":"Aasen Thomas H","source":"filing","n_filings":14,"first_seen":"2006-02-17","last_seen":"2014-04-04"}],"transactions":[{"id":6686240,"accession":"0001415889-14-001112","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-001112","line_url":"/filing/0001415889-14-001112#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":22.484,"price_display":"22.48","price_state":"stated","total_value":337260.0,"total_display":"337,260.00","total_whole":"337,260","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-04-04","filed_date":"2014-04-04","scope":"insider"},{"id":6326705,"accession":"0001415889-14-000033","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-14-000033","line_url":"/filing/0001415889-14-000033#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":24.8778,"price_display":"24.88","price_state":"stated","total_value":746334.0,"total_display":"746,334.00","total_whole":"746,334","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":4892860,"accession":"0001415889-13-001969","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-13-001969","line_url":"/filing/0001415889-13-001969#line-5","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":27.8707,"price_display":"27.87","price_state":"stated","total_value":836121.0,"total_display":"836,121.00","total_whole":"836,121","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-03","scope":"insider"},{"id":5215948,"accession":"0001415889-13-001643","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-13-001643","line_url":"/filing/0001415889-13-001643#line-5","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":20.153,"price_display":"20.15","price_state":"stated","total_value":1209180.0,"total_display":"1,209,180.00","total_whole":"1,209,180","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-13","filed_date":"2013-08-15","scope":"insider"},{"id":4697171,"accession":"0001415889-13-000739","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-13-000739","line_url":"/filing/0001415889-13-000739#line-6","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":11.06,"price_display":"11.06","price_state":"stated","total_value":442400.0,"total_display":"442,400.00","total_whole":"442,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-11","filed_date":"2013-04-12","scope":"insider"},{"id":5031726,"accession":"0001415889-13-000632","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-13-000632","line_url":"/filing/0001415889-13-000632#line-5","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":7.6771,"price_display":"7.68","price_state":"stated","total_value":307084.0,"total_display":"307,084.00","total_whole":"307,084","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-04-01","filed_date":"2013-04-03","scope":"insider"},{"id":2587209,"accession":"0001415889-12-001792","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-12-001792","line_url":"/filing/0001415889-12-001792#line-7","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9100.0,"shares_display":"9,100","price_per_share":5.2499,"price_display":"5.25","price_state":"stated","total_value":47774.09,"total_display":"47,774.09","total_whole":"47,774","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-11-28","filed_date":"2012-11-29","scope":"insider"},{"id":2587184,"accession":"0001415889-12-001792","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-12-001792","line_url":"/filing/0001415889-12-001792#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (EXEC VP, CFO AND CBO)","role_mark":"O","role_mark_label":"Officer (EXEC VP, CFO AND CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXEC VP, CFO AND CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30900.0,"shares_display":"30,900","price_per_share":6.2414,"price_display":"6.24","price_state":"stated","total_value":192859.26,"total_display":"192,859.26","total_whole":"192,859","shares_owned_after":4100.0,"shares_owned_after_display":"4,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-11-27","filed_date":"2012-11-29","scope":"insider"},{"id":3407844,"accession":"0001181431-08-010653","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-08-010653","line_url":"/filing/0001181431-08-010653","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark":"O","role_mark_label":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Pres., CFO, Treas. & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.835,"price_display":"10.84","price_state":"stated","total_value":86680.0,"total_display":"86,680.00","total_whole":"86,680","shares_owned_after":6334.0,"shares_owned_after_display":"6,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-13","filed_date":"2008-02-14","scope":"insider","n_lines":3},{"id":7044126,"accession":"0001181431-07-074148","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-07-074148","line_url":"/filing/0001181431-07-074148","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark":"O","role_mark_label":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Pres., CFO, Treas. & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.025,"price_display":"12.02","price_state":"stated","total_value":48100.0,"total_display":"48,100.00","total_whole":"48,100","shares_owned_after":9864.0,"shares_owned_after_display":"9,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-06","filed_date":"2007-12-07","scope":"insider","n_lines":2},{"id":7262144,"accession":"0001181431-07-070145","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-07-070145","line_url":"/filing/0001181431-07-070145","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark":"O","role_mark_label":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Pres., CFO, Treas. & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":11.170125,"price_display":"11.17","price_state":"stated","total_value":89361.0,"total_display":"89,361.00","total_whole":"89,361","shares_owned_after":6334.0,"shares_owned_after_display":"6,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-11-14","filed_date":"2007-11-16","scope":"insider","n_lines":4},{"id":7545279,"accession":"0000898430-07-003388","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000898430-07-003388","line_url":"/filing/0000898430-07-003388","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark":"O","role_mark_label":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Pres., CFO, Treas. & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":15.5575,"price_display":"15.56","price_state":"stated","total_value":248920.0,"total_display":"248,920.00","total_whole":"248,920","shares_owned_after":16334.0,"shares_owned_after_display":"16,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-15","filed_date":"2007-08-17","scope":"insider","n_lines":5},{"id":4445554,"accession":"0001181431-06-049945","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-06-049945","line_url":"/filing/0001181431-06-049945#line-5","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark":"O","role_mark_label":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Pres., CFO, Treas. & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":64000.0,"total_display":"64,000.00","total_whole":"64,000","shares_owned_after":12500.0,"shares_owned_after_display":"12,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-08-24","filed_date":"2006-08-28","scope":"insider"},{"id":3742991,"accession":"0001181431-06-032194","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-032194","line_url":"/filing/0001181431-06-032194#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark":"O","role_mark_label":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Pres., CFO, Treas. & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":10.67,"price_display":"10.67","price_state":"stated","total_value":85360.0,"total_display":"85,360.00","total_whole":"85,360","shares_owned_after":16500.0,"shares_owned_after_display":"16,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-18","filed_date":"2006-05-22","scope":"insider"},{"id":3482608,"accession":"0001181431-06-012918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-012918","line_url":"/filing/0001181431-06-012918#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001291969","owner_name":"Aasen Thomas H","owner_display_name":"Aasen Thomas H","owner_url":"/insider/0001291969","role":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark":"O","role_mark_label":"Officer (Vice Pres., CFO, Treas. & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice Pres., CFO, Treas. & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":15.1,"price_display":"15.10","price_state":"stated","total_value":181200.0,"total_display":"181,200.00","total_whole":"181,200","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-02-15","filed_date":"2006-02-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EXEC VP, CFO AND CBO)","n_filings":14,"first_seen":"2006-02-17","last_seen":"2014-04-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291969","retrieved_at":"2026-08-22T08:28:25+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}